“Pharmacological blockade of protease-Activated Receptor 2 improves airway remodeling and lung inflammation in experimental allergic asthma”, Braz. J. Pharm. Sci., vol. 58, Feb. 2023, doi: 10.1590/s2175-97902022e201089.